Clinical Trials Browser

Withdrawn × Recurrence × pomalidomide × Clear all

NCT06232707 2024-05-31

ALUMMINATE

Phase 3 Withdrawn

Multiple Myeloma, Recurrence

NCT05408026 2023-01-27

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Phase 1/2 Withdrawn

Multiple Myeloma, Recurrence

NCT02578121 2017-01-23

UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination

Phase 2 Withdrawn

Multiple Myeloma, Recurrence